Cadila Healthcare signs agreement to extend tenure of JVA with Bayer

21 Jun 2021 Evaluate

Cadila Healthcare has signed an agreement to extend the tenure of the joint venture agreement (JVA) with Bayer (South East Asia) PTE, one of the companies of the Bayer Group, for a period of three years. The amendment is to extend the term of the JVA for a period of three years till May 1, 2024. The company believes that the extension of the JVA would be beneficial considering the prospects of the growth of the JV over next three years.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

935.15 -24.40 (-2.54%)
24-Apr-2024 14:36 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1486.80
Dr. Reddys Lab 5944.85
Cipla 1396.65
Zydus Lifesciences 935.15
Lupin 1582.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.